top of page

Collaborative Innovation with key suppliers and/or with technical partners or consortia can be harnessed for the following innovative activities:

  • creating new products or services

  • finding novel ways to eliminate cost and waste, improve sustainability, whether from products, supply chains, or manufacturing operations

  • sharing data to build new types of customer offerings.

Supplier innovation is a critical component of supplier collaboration
Ref:McKinsey Consultants

Why innovate through an external collaboration as opposed to wholly in-house activity?

  1. Externally sourced innovations are commercialised 40% faster than home-grown ideas.

  2. Between 55-65% of enterprise innovation is typically sourced externally

  3. 196% net income growth of companies that regularly innovate with suppliers vs companies that don’t at all.

Innovation through collaboration has had huge growth over recent decades. Collaboration can be across a wide range of sectors from finance/investment, pre-clinical R&D, clinical trials, manufacture, drug delivery & formulation, operations and process design,packaging and logistics. CDMO's are taking on the role of a co-developer or collaborator in projects rising above the traditional supplier position and role.

Managing successfully the innovation process in relation to external parties underpins the advantages of collaborating in the first place. To realise the benefits of sharing and co-operating one must have a strong process to share information and have the right structures in place to satisfy both internal management but also for a future regulatory oversight once a project advances. We can help you from partner selection through qualification, document exchange and management through to project and tasks management. Identifying and monitoring risk in a partnership is included in all our software applications. If you would like a demo of our applications please get in contact through the email address below.

For a look at our collaborative platform go to

or for more information contact me at

Smart identification and on-boarding of suppliers reduces your risk of poor vendor choices.

It also cuts the time needed to verify new suppliers and can integrate with your own risk management strategy around each vendor.

We have thousands of quality suppliers searchable on our database with a search engine specifically designed for the pharmaceutical, medical device and healthcare needs.

Surims Ltd have designed and launched a full range of applications to support your vendor diversification programs. These applications provide a systemic way of identifying and managing a successful supply base.The applications support risk management initiatives you have in managing vendors.

When searching for alternative suppliers, the search engine can closely fit your geographical, quality and technical requirements. Our database allows you to search in a way that matches your business, operational and quality needs.

Successfully on-board suppliers that fit your criteria by having them to provide you with a wide range of information on their company giving a balanced holistic review of their operations.

Prioritise, tier, score your suppliers so that you can successfully qualify and manage your vendors.

Qualify your suppliers by building and deploying (with our suppliers) on-line questionnaires and assessments. Score received responses and share comments and reporting with your supplier (optional)

Create successful vendor RFQ's and share them privately with specific vendors. Then manage the response and eventual awarding of future contracts and business with a successful vendor.

Our project management application supports either an initial engagement with a supplier or more complex long term supplier interactions. You are able to setup milestones and taks and share these both internally and with your outside vendor. Also set up risk with any project and apply mitigating tasks to these risks.

Exchange documents with your suppliers or partners for approval or their signature. All stages are tracked from the initial exchange right through to approval and signature.


Having technology that closely maps your existing qualification process but also provides a reproducible and standardised method of managing vendors, reduces risk associated with a new or existing supplier or vendor diversification. Our applications greatly reduce the time taken to validate a company compared to older traditional methods, paper, fax, spreadsheets e.t.c. The applications also support a partnership status for further collaboration and increase the productivity of your relationship to improve or reduce time associated with research and development or actual production.

For further information please visit

Updated: Nov 15, 2023

Supply-base transparency can be hard to achieve. In global supply chains, hundreds or even thousands of suppliers may contribute to the production of a single product. Identifying the full set of suppliers from the early raw-material sources, to a finished product, can require a significant time investment.

Your suppliers may consider their own supply chains and processes to be proprietary, they can limit visibility to you the purchaser. This can all be further complicated by the presence of a intermediary or agent. This lack of transparency with your supplier presents risk, so having a robust process of identification and qualification sets an early mandate with your suppliers to establish a set of risk management processes that both the buyer and seller participate in and that lack of participation is a risk in itself.

We suggest right from the start, in supplier identification processes to have a clear idea of 'what good looks like' in terms of a supplier and then translate this into an actual search criteria. We can help you here with a search engine developed specifically for searching for quality suppliers in the pharma and healthcare sector.

This for example allows you to combine both technical and regulatory requirements along with location (see graphic below)

Once you have identified a suitable company or a number of companies that could possibly supply, then have a common process and set of data that you collect on a prospective supplier. Having a supplier engage in this process of data collection and support you in building a profile on them is key in the eventual risk management process. Do they become involved in the initial registration process?, do they volunteer basic information on themselves? or engage in longer term up-dating of the profile? All can be indicators of their commitment to become a value supplier to your company.

Below is an example of a standardised registration process, on-boarding, for a supplier along with a wide range of data, providing useful and verifiable information on the company.

We suggest organisations begin to tackle issues in a structured way, putting in place processing supported by digital tools in supplier qualification and addressing identified known risks. while improving the organisation's resilience for the inevitable unknown risk that becomes a problem in the future.

Organisations should invest time with a cross-functional team to catalogue a full scope of risks they face. Building a risk-management framework, that determines which metrics are appropriate for measuring risks and “what good looks like” for each metric, and how to rigorously track and monitor these metrics. This team can also identify grey areas where risks are hard to understand or define (e.g parts of the supply chain where no visibility exists).

Below is a graphic showing our 'My Companies' application allowing you to score, tier and manage on-line activities with your key suppliers.

Organisations can use a combination of structured problem solving and digital tools to effectively manage their known-risk portfolio through four steps:

Step 1: Identify and document risks. A typical approach for risk identification is to map out and assess the value chains of all major products. Each point of the supply chain—suppliers, plants, warehouses, and transport routes. Risks are entered on a risk register and tracked rigorously on an ongoing basis. In this step, parts of the supply chain where no data exist and further investigation is required should also be recorded.

Step 2: Build a supply-chain risk-management framework Every risk in the register should be scored based on three dimensions to build an integrated risk management framework including the impact on the organisation if the risk materialises also the probability of the risk materialising, and the organisation's preparedness to deal with that specific risk. Weightings are applied on the risk scores reflecting the organisation's risk appetite. It is critical to use a consistent scoring methodology to assess all risks. This allows for prioritising to identify the highest-risk products and supply-chain points/nodes with the greatest failure potential.

The use of questionnaires either at the very start or throughout the relationship with a supplier can be very important to gather information and identify risk. They can form a pillar of the over-all process of contanting monitoring and checking on overall risk or specific (maybe new) requirements in a supplier relationship. It is an advantage to have a standard set of questionnaires used by your team over all suppliers so that it does standardise the collection of data and therefore the identification and mitigation of risk can fform part of a process and method.

Step 3: Monitor risk once a risk-management framework is established, persistent monitoring is one of the critical success factors in identifying risks that may damage an organisation. Set tasks (with both internal and external stakeholders) resulting from the identified risks. Score the tasks and have them included in the overall risk factor. Both suppliers and a buyer are then part of the process, by completing tasks successfully, in reducing risk scores.The recent emergence of digital tools has made this possible for most supply chains to identify and track the leading indicators of risk.

For example, a large organisation operating in a regulated industry identified 25 leading indicators of quality issues at its plants and contract manufacturers, ranging from structural drivers including geographical location and number of years in operation to operational performance metrics, such as “right first me” and deviation cycle times. These 25 indicators were carefully weighted to develop a quality risk-exposure score, and then tracked on a regular cadence.

Successful monitoring systems are customised to an organisation's needs, incorporation impact, likelihood, and preparedness perspectives. Hence, while one organisation may track deviations on manufacturing lines to predict quality issues, another may follow real-time Caribbean weather reports to monitor hurricane risk at its plants in Puerto Rico. Regardless, it is critical to have an early warning system to track top risks to maximise the chances of mitigation, or at the very least timing, the impact from their occurrence.

Step 4: Institute governance and regular review The final critical step is to set up a robust governance mechanism to periodically review supply chain risks and define mitigating actions, improving the resilience and agility of the supply chain.

Having a system for a manager to view across all users and stakeholders what risks they have identified and associated mitigating tasks and scores. There should be no silos or lack of transparency either internally or with suppliers, it becomes a risk in itself you you measure lack of openness and sharing of data from your supplier.

Building a risk-aware culture helps an organisation both establish and maintain strong defensive layers against unknown risks. Management and employees need to feel empowered to pass on bad news and lessons from mistakes. This openness fosters an environment where it is okay to voice and deal with issues. Culturally, it is critical that the organisation not get discouraged or point fingers when a risk event occurs, and instead works harmoniously towards a rapid resolution's. Transparency.

Leaders must clearly define and communicate an organisation's risk tolerance. Risk mitigation has an associated incremental cost, and so it is important to align on which risks need to be mitigated and which can be borne by the organisation. An organisation's culture should also allow for warning signs of both internal and external risks to be openly shared. Employees need to be empowered to perceive and react rapidly to external change. This can be enabled by creating an ownership environment, where members feel responsible for outcome of actions and decisions. Employees’ risk appetites should be aligned with an organisation, so that individuals or groups do not take risks or actions that benefit themselves but harm the broader organisation.

For further information on our digital tools and application to support you in the identification of risk and management of suppliers and technical partners in the pharma and healthcare sector, please have a look at and or contact me at

bottom of page